<section class="pt-[100px] pb-[100px] xl:pb-[100px] bg-white dark:bg-background-5">
  <div class="main-container">
    <div
      class="flex lg:items-end items-center lg:flex-row flex-col lg:gap-0 gap-4 justify-between mb-[70px]"
    >
      <div class="flex-1 lg:text-left text-center">
        <div class="space-y-3">
          <span data-ns-animate data-delay="0.1" class="badge badge-green" data-i18n="pharma.value.badge">Value</span>
          <h2 data-ns-animate data-delay="0.2" class="max-w-[600px]" data-i18n="pharma.value.title">
             FDA Compliance without the Overhead
          </h2>
          <p data-ns-animate data-delay="0.3" class="max-w-[780px]" data-i18n="pharma.value.subtitle">
            Mid-sized biotechs shouldn't be priced out of innovation. We provide the specific Molecular GNN technology required to navigate FDA Modernization Act 2.0, allowing you to replace costly animal trials with precise <em>in silico</em> New Approach Methodologies (NAMs).
          </p>
        </div>
      </div>
    </div>
    
    <div class="grid grid-cols-12 lg:gap-8 gap-y-14">
      
      <div data-ns-animate data-delay="0.4" class="col-span-12 lg:col-span-4">
        <div class="space-y-6">
          <div class="max-lg:text-center">
            <span class="ns-shape-116 text-[52px] text-secondary dark:text-accent"></span>
          </div>
          <div class="space-y-1 lg:text-left text-center">
            <h3 class="text-heading-5" data-i18n="pharma.value.items.geometry.title">3D Molecular Topology</h3>
            <p class="max-w-[338px] lg:mx-0 mx-auto" data-i18n="pharma.value.items.geometry.description">
              Standard AI treats molecules like flat images. We use Geometric Deep Learning that understands 3D topology and rotational invariance. This allows us to accurately predict binding affinity where other "black box" models fail.
            </p>
          </div>
        </div>
      </div>

      <div data-ns-animate data-delay="0.5" class="col-span-12 lg:col-span-4">
        <div class="space-y-6">
          <div class="max-lg:text-center">
            <span class="ns-shape-12 text-[52px] text-secondary dark:text-accent"></span>
          </div>
          <div class="space-y-1 lg:text-left text-center">
            <h3 class="text-heading-5" data-i18n="pharma.value.items.toxicity.title">Early Toxicity Screening</h3>
            <p class="max-w-[313px] lg:mx-0 mx-auto" data-i18n="pharma.value.items.toxicity.description">
              Late-stage failure is the most expensive cost in pharma. Our Graph Neural Networks screen millions of candidates for toxicity risks (ADMET) in minutes, ensuring you only advance viable candidates to wet-lab trials.
            </p>
          </div>
        </div>
      </div>

      <div data-ns-animate data-delay="0.6" class="col-span-12 lg:col-span-4">
        <div class="space-y-6">
          <div class="max-lg:text-center">
            <span class="ns-shape-107 text-[52px] text-secondary dark:text-accent"></span>
          </div>          
          <div class="space-y-1 lg:text-left text-center">
            <h3 class="text-heading-5" data-i18n="pharma.value.items.explainable.title">Explainable AI</h3>
            <p class="max-w-[337px] lg:mx-0 mx-auto" data-i18n="pharma.value.items.explainable.description">
              Regulators reject Black Boxes. We use Physics-Informed models that respect biological laws, making them auditable.
            </p>
          </div>
        </div>
      </div>

      <div data-ns-animate data-delay="0.4" class="col-span-12 lg:col-span-4">
        <div class="space-y-6">
          <div class="max-lg:text-center">
            <span class="ns-shape-55 text-[52px] text-secondary dark:text-accent"></span>
          </div>          
          <div class="space-y-1 lg:text-left text-center">
            <h3 class="text-heading-5" data-i18n="pharma.value.items.nam.title">FDA 2.0</h3>
            <p class="max-w-[337px] lg:mx-0 mx-auto" data-i18n="pharma.value.items.nam.description">
              The FDA Modernization Act 2.0 authorizes non-animal testing methods. Our models are purpose-built to serve as high-fidelity NAMs, helping you clear regulatory hurdles faster using verifiable computational data.
            </p>
          </div>
        </div>
      </div>

      <div data-ns-animate data-delay="0.5" class="col-span-12 lg:col-span-4">
        <div class="space-y-6">
          <div class="max-lg:text-center">
            <span class="ns-shape-123 text-[52px] text-secondary dark:text-accent"></span>
          </div>
          <div class="space-y-1 lg:text-left text-center">
            <h3 class="text-heading-5" data-i18n="pharma.value.items.data.title">Data Efficiency</h3>
            <p class="max-w-[338px] lg:mx-0 mx-auto" data-i18n="pharma.value.items.data.description">
              You don't need Google-sized datasets. Our PINNs use physical constraints to learn accurately from smaller, proprietary datasets.
            </p>
          </div>
        </div>
      </div>

    </div> 
  </div>
</section>